• Anlotinib Hydrochloride: From Target to Assay

  2026-08-27

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor whose value in cancer research depends on interpreting receptor, pathway, and phenotype data together. This guide develops an assay-decision framework that separates VEGFR2-driven endothelial effects from broader angiogenic signaling and direct tumor-cell responses.

• SCH772984: ERK Signaling at the Resistance Edge

  2026-08-27

  A translational framework for using SCH772984, a selective ERK1/2 inhibitor, to test whether MAPK signaling connects angiotensin II, HIF-1α-HILPDA biology, ferroptosis suppression, and radioresistance in nasopharyngeal carcinoma.

• Gli1+ Progenitors in Glucocorticoid Osteoporosis

  2026-08-26

  Yang et al. identify Gli1+ metaphyseal mesenchymal progenitors as a key osteoblast-lineage population affected by glucocorticoid-induced osteoporosis. By combining inducible lineage tracing, single-cell RNA sequencing, metabolic analysis, and teriparatide treatment, the study links progenitor dysfunction to impaired bone formation and highlights a candidate cellular target for intervention.

• Spermine tetrahydrochloride: Applied Workflows

  2026-08-26

  Spermine tetrahydrochloride is a charge-based reagent for protecting bacterial protoplasts, improving protein crystallization, and crosslinking polyphosphazene nanoparticles. This guide converts published concentration ranges into practical workflows, controls, and troubleshooting decisions while separating established evidence from exploratory applications.

• CDC42–YAP–mTOR Control of Intestinal Stem Cell Fate

  2026-08-25

  Zhang et al. show that CDC42-dependent apical-basal polarity regulates the intestinal stem cell-to-transit amplifying cell transition through a YAP/TAZ–Ereg–mTOR cascade rather than canonical Wnt signaling. Conditional genetics and pharmacological rescue experiments distinguish restoration of cell-fate balance from restoration of epithelial polarity, providing a mechanistic framework for intestinal crypt homeostasis.

• Hydroxycinnamic Acids Block COPII–STING Trafficking

  2026-08-25

  This study identifies the Sec24 B-site of the COPII coat complex as a molecular target of cinnamic, caffeic, and ferulic acids. Structural, cellular, and diabetic mouse experiments connect competitive disruption of STING trafficking with reduced TBK1/IRF3 signaling, improved metabolic control, and less hepatic injury.

• Olive Biophenols and Alzheimer’s Pathology

  2026-08-24

  The reference study combined SH-SY5Y cell assays with an APPswe/PS1dE9 mouse model to examine whether olive biophenols could limit amyloid-β42 toxicity, aggregation, and plaque deposition. Its most meaningful finding was that oleuropein-rich olive preparations, along with verbascoside and rutin, showed protective and anti-amyloid activity across complementary experimental systems, while remaining subject to important bioavailability and translational limitations.

• H 89 2HCl: PKA Causality in Bone Cells

  2026-08-24

  H 89 2HCl enables mechanistic analysis of cAMP-dependent protein kinase inhibition beyond simple pathway blocking. This article explains how to use it to distinguish cAMP, PKA, CREB, and osteoclast phenotypes while accounting for concentration-dependent kinase selectivity.

• Angiotensin I/II (1-5) Workflow Guide

  2026-08-23

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation, renal physiology, and aldosterone signaling. It is appropriate for cardiovascular and renal workflows, but its water insolubility and lack of paper-specific validation in this brief require explicit solvent controls and empirical assay optimization.

• Patient-Derived 3D Spheroids in Prostate Cancer

  2026-08-22

  The reference study established viable three-dimensional spheroid cultures from organ-confined prostate cancer tissue obtained during radical prostatectomy. Its findings show that these patient-derived cultures preserve key epithelial and androgen receptor-associated features, tolerate cryopreservation, and support comparative drug-response testing, creating a practical bridge between tissue pathology and translational prostate cancer research.

• From mRNA Trafficking to Translational Confidence

  2026-08-22

  Translational mRNA research increasingly depends on measuring not only whether a construct enters cells, but where it travels, whether it remains functional, and how delivery biology shapes therapeutic output. This thought-leadership article connects those measurement needs to the stroke-focused mRNA nanoparticle work reported in ACS Nano and positions ARCA Cy5 EGFP mRNA (5-moUTP) as a practical reporter for building more decision-ready delivery studies.

• Caspase-3, Coronin 1B, and Melanoma Motility

  2026-08-21

  A 2025 Cell Death and Disease study identifies a non-apoptotic role for caspase-3 in melanoma migration and invasion. The work links constitutive cytoskeletal caspase-3 to coronin 1B activity and places SP1 upstream of CASP3 expression, refining how apoptosis-associated proteins should be interpreted in cancer biology.

• Gap19 for Cx43 Hemichannel Research

  2026-08-20

  Gap19 is a selective connexin 43 hemichannel blocker for separating Cx43 hemichannel signaling from gap junction communication. Its value spans astrocyte ATP-release assays, AngII-driven macrophage polarization, and translational models of cerebral ischemia, provided concentration, formulation, and route are controlled carefully.

• 2-D08: Selective Sumoylation Inhibition

  2026-08-20

  2-D08, also called 2’,3’,4’-trihydroxyflavone, is a selective posttranslational modification inhibitor that blocks SUMO transfer from UBC9-SUMO to substrate proteins. Its strongest reported application is mechanistic sumoylation inhibition in cancer research, including topoisomerase I sumoylation inhibition in breast cancer cells, while animal and clinical validation remains unavailable.

• Caspase-3, NDUFS1, and ROS in Trichothecene Injury

  2026-08-19

  This non-peer-reviewed preprint identifies a caspase-3/NDUFS1 pathway that links trichothecene exposure to mitochondrial complex I disruption and ROS amplification, while also implicating ER-localized ERO1α as an independent oxidative source. Its combined in vivo, in vitro, inhibition, expression-suppression, and cleavage-site-mutant design offers a useful framework for separating mitochondrial dysfunction from broader oxidative stress.

8062 records 1/538 page Next 12345 下5页 Last page